Feasibility of bevacizumab (BEV) plus chemotherapy in heavily pretreated ovarian cancer (OC) patients (pts): A retrospective study. Background: Rising serum cancer antigen 125 (CA-125) trends within ...
The molecular evolution of prostate cancer cell line exosomes with passage number. Role of the p38αMAPK in the prognosis and prediction of response to neoadjuvant chemotherapy in locally advanced ...
Current treatment guidelines recommend using cancer antigen-125 (CA-125) as a diagnostic marker for ovarian cancer recurrence, but a recent study suggests CA-125 has poor concordance with progressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results